Measurement of cerebral perfusion after zolpidem administration in the baboon model

Citation
Rp. Clauss et al., Measurement of cerebral perfusion after zolpidem administration in the baboon model, ARZNEI-FOR, 51(8), 2001, pp. 619-622
Citations number
17
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
ISSN journal
00044172 → ACNP
Volume
51
Issue
8
Year of publication
2001
Pages
619 - 622
Database
ISI
SICI code
0004-4172(2001)51:8<619:MOCPAZ>2.0.ZU;2-7
Abstract
`A recent report showed that zolpidem (CAS 82626-48-0) can lead to the arou sal of a semi-comatosed patient. Zolpidem is clinically used for the treatm ent of insomnia. It belongs to the imidazopyridine chemical class and is a non benzodiazepine drug. It illicits its pharmacological action via the GAB A receptor system through stimulation of particularly the omega (1) recepto rs. In this study, the effect of zolpidem on brain perfusion was examined b y Tc-99m hexamethyl-propylene amine oxime (HMPAO) split dose brain SPECT on four normal baboons and in one baboon with abnormal neurological behaviour . The global and regional brain perfusion was not significantly affected in the normal brains. In some regions of the abnormal baboon brain, however, there was a disproportionate increase in perfusion after zolpidem.